Hang Seng Indexes Company today announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 September 2025. For the Hang Seng Index, INNOVENT BIO (01801.HK) -6.400 (-6.957%) Short selling $401.86M; Ratio 8.723% will be added. The total number of constituents will increase from 88 to 89. All changes will be implemented after market close on 5 December 2025 (Friday) and take effect on 8 December 2025 (Monday).(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-12-08 16:25.)Related NewsUBS Expects INNOVENT BIO's New Product Sales to Ramp up Next Yr, w/ $137.4 TP